BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $23,684,000 | +68.4% | 460,154 | +21.0% | 0.03% | +45.0% |
| Q4 2018 | $14,062,000 | +234.0% | 380,273 | +239.1% | 0.02% | +566.7% |
| Q3 2018 | $4,210,000 | +95.6% | 112,126 | +105.9% | 0.00% | 0.0% |
| Q2 2018 | $2,152,000 | +42.3% | 54,452 | -7.2% | 0.00% | +50.0% |
| Q1 2018 | $1,512,000 | +182.1% | 58,697 | +195.5% | 0.00% | +100.0% |
| Q4 2017 | $536,000 | -55.3% | 19,861 | -38.1% | 0.00% | -50.0% |
| Q3 2017 | $1,200,000 | +169.7% | 32,097 | +80.4% | 0.00% | +100.0% |
| Q2 2017 | $445,000 | – | 17,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |